A significant increase in plasma urea concentration was observed in the CIS-treated Gal-3 wild-type mice compared to Gal-3 wild-type sham control mice, indicating statistical significance (p < 0.001) (Figure 1A). Here, LGALS3 is linked to in situ carcinoma.